# Michael J. Morris

Source: https://onco.cc/people/michael-morris/  
OnCo record `michael-morris` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Principal investigator of the VISION trial that made lutetium-PSMA a standard prostate cancer treatment.

## Summary

Michael J. Morris is Prostate Cancer Section Head on the Genitourinary Oncology Service at Memorial Sloan Kettering Cancer Center. He is a medical oncologist known as principal investigator of the VISION trial, which made lutetium-177 PSMA radioligand therapy a standard prostate cancer treatment, and co-led PSMAfore and PSMA PET studies. His selected papers report lutetium-177 PSMA-617 for metastatic castration-resistant prostate cancer and the PSMAfore comparison against a change of androgen receptor pathway inhibitor in taxane-naive patients. He chaired the Alliance genitourinary committee and focuses on radioligand therapy and imaging biomarkers.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Prostate Cancer Section Head, Genitourinary Oncology Service
- Specialisms: Prostate cancer; Radiopharmaceuticals; PSMA theranostics

## Sources

- MSK profile: https://www.mskcc.org/cancer-care/doctors/michael-morris
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Morris%20MJ%5BAuthor%5D

## Connected records

- cancers: [Prostate cancer](https://onco.cc/cancers/prostate/)
- technologies: [PSMA PET](https://onco.cc/technologies/psma-pet/), [Radioligand therapy (beta emitters)](https://onco.cc/technologies/radioligand-therapy/)
- targets: [PSMA](https://onco.cc/targets/psma/)
- drugs: [Lutetium-177 vipivotide tetraxetan](https://onco.cc/drugs/pluvicto/)
- institutions: [Memorial Sloan Kettering Cancer Center](https://onco.cc/institutions/mskcc/)
- trials: [PSMAfore](https://onco.cc/trials/psmafore/), [VISION](https://onco.cc/trials/vision/)
- key papers: [VISION: lutetium-177 PSMA-617 radioligand therapy extends survival in advanced prostate cancer](https://onco.cc/key-papers/paper-vision-nejm-2021/)

---
JSON: https://onco.cc/api/v1/entities/michael-morris.json